We tracked two longitudinal metrics: 12-month new GLP-1 initiation rates among newly diagnosed PMOS patients
Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes
Introduction Atherosclerosis (AS) is a disease of large- and medium-sized arteries and is characterized by endothelial dysfunction, vascular inflammation, and the buildup of lipids, cholesterol, calcium, and cellular debris within the vessel wall intima
Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort affect a significant proportion of patients, though symptoms typically improve over time as the body adjusts to the medication
Arthritis The use of GLP-1 drugs is associated with an 11% increase in arthritis risk, according to a large study published in Nature Medicine in January 2025
It also warned that any continued manufacturing outside these boundaries could prompt enforcement action